Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease
- PMID: 38987826
- PMCID: PMC11234521
- DOI: 10.1186/s13195-024-01507-7
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease
Erratum for
-
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.Alzheimers Res Ther. 2024 May 10;16(1):105. doi: 10.1186/s13195-024-01441-8. Alzheimers Res Ther. 2024. PMID: 38730496 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
